Journals / Osmangazi Tıp Dergisi / 2026 / Cilt: 48 Sayı: 5

Antimicrobial Resistance Profile of Uropathogenic Escherichia coli Isolates: A Single-Center Retrospective Surveillance Study

Üropatojen Escherichia coli İzolatlarında Antimikrobiyal Direnç Profili: Tek Merkezli Retrospektif Bir Sürveyans Çalışması

Mustafa Kocaağa(SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, ESKİŞEHİR ŞEHİR SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, TEMEL TIP BİLİMLERİ BÖLÜMÜ, TIBBİ MİKROBİYOLOJİ ANABİLİM DALI)0000-0003-4150-1947
Naciye Betul Baysal(ESKİŞEHİR YUNUS EMRE DEVLET HASTANESİ ENFEKSİYON HASTALIKLARI ve KLİNİK MİKROBİYOLOJİ)0000-0003-4432-4296
Pages
950–955
Publication Date
2026-08-26
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Continuous surveillance of local antimicrobial resistance patterns is essential for updating empirical treatment strategies and supporting antimicrobial stewardship.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:This study aimed to determine the antimicrobial resistance rates of uropathogenic Escherichia coli strains isolated from urine cultures and to guide empirical therapy.
📊
Key Findings & Data:A total of 1,811 E. coli isolates obtained from patients aged ≥18 years between August 2024 and July 2025 were retrospectively analyzed.
💡
Conclusion & Impact:Continuous surveillance of local antimicrobial resistance patterns is essential for updating empirical treatment strategies and supporting antimicrobial stewardship.
🔬Design:Araştırma Makalesi
📍Scope:2024 Verileri
⚙️Variables:Escherichia coli · Antibiyotik · Ampirik tedavi.

Abstract

This study aimed to determine the antimicrobial resistance rates of uropathogenic Escherichia coli strains isolated from urine cultures and to guide empirical therapy. A total of 1,811 E. coli isolates obtained from patients aged ≥18 years between August 2024 and July 2025 were retrospectively analyzed. Identification and antimicrobial susceptibility testing were performed using conventional methods and the BD Phoenix™ M50 automated system. Results were interpreted according to EUCAST criteria. A total of 81.9% of the isolates were obtained from female patients. The prevalence of ESBL-producing isolates was 25.9%. The highest resistance rates were observed for ampicillin (73.4%) and amoxicillin-clavulanic acid (64.1%). In contrast, resistance rates to nitrofurantoin (4.2%), amikacin (2.4%), and carbapenems (imipenem, 0.8%; meropenem, 0.9%) remained low. High resistance rates to β-lactams and fluoroquinolones among uropathogenic Escherichia coli isolates in our region substantially limit empirical treatment options. Nitrofurantoin remains an appropriate empirical treatment option for uncomplicated urinary tract infections, whereas carbapenems should be reserved for infections caused by resistant isolates. Continuous surveillance of local antimicrobial resistance patterns is essential for updating empirical treatment strategies and supporting antimicrobial stewardship.

Özet

Bu çalışmada, idrar kültürlerinden izole edilen üropatojen Escherichia coli suşlarının antibiyotik direnç oranlarının belirlenmesi ve ampirik tedaviye rehberlik edilmesi amaçlanmıştır. 01.08.2024–31.07.2025 tarihleri arasında 18 yaş üstü hastalardan izole edilen 1811 E. coli suşu retrospektif olarak incelendi. Tanımlama ve antibiyotik duyarlılık testleri konvansiyonel yöntemler ve BD Phoenix™ M50 sistemi ile yapıldı. Sonuçlar EUCAST kriterlerine göre değerlendirildi. İzolatların %81,9'u kadın hastalardan elde edildi. ESBL pozitiflik oranı %25,9 olarak saptandı. En yüksek direnç ampisilin (%73,4) ve amoksisilin-klavulanik aside (%64,1) karşı gözlendi. Nitrofurantoin (%4,2), amikasin (%2,4) ve karbapenemlere (imipenem %0,8; meropenem %0,9) karşı direnç düşük bulundu. Bölgemizde üropatojen E. coli suşlarında beta-laktamlar ve kinolonlara karşı yüksek direnç oranları ampirik tedavi seçeneklerini kısıtlamaktadır. Nitrofurantoin, komplike olmayan üriner sistem enfeksiyonlarında etkinliğini koruyan uygun bir ampirik tedavi seçeneği olarak öne çıkarken, karbapenemler dirençli olgularda korunması gereken ajanlardır. Lokal antimikrobiyal direnç verilerinin düzenli olarak izlenmesi, ampirik tedavi stratejilerinin güncellenmesi açısından önem taşımaktadır.

🔖

Cite This Article

Kocaağa, M., Baysal, N. B. (2026). Antimicrobial Resistance Profile of Uropathogenic Escherichia coli Isolates: A Single-Center Retrospective Surveillance Study. Osmangazi Tıp Dergisi, Cilt: 48 Sayı: 5, 950–955. https://doi.org/10.20515/otd.1895021

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Foxman B. The Epidemiology Of Urinary Tract İnfection. Nat Rev Urol. 2010;7(12):653-60.
  2. Farrell DJ, Morrissey I, De Rubeis D, Robbins M, Felmingham D. A UK Multicentre Study Of The Antimicrobial Susceptibility Of Bacterial Pathogens Causing Urinary Tract İnfection. J Infect. 2003;46(2):94-100.
  3. Sierra-Díaz E, Hernández-Ríos CJ, Bravo-Cuellar A. Antibiotic Resistance: Microbiological Profile Of Urinary Tract İnfections İn Mexico. Cir Cir. 2019;87(2):176-82.
  4. Kalaycı HÖ, Çalgın MK, İbik YE. Investigation Of Antibiotic Susceptibility Profiles Of Escherichia Coli Strains Grown İn Urine Cultures. Middle Black Sea Journal Of Health Science. 2025;11(3):151-9.
  5. Baran C, Küçükcan A. Antimicrobial Susceptibility Of Bacteria İsolated From Urine Cultures İn Southern Turkey. Curr Urol. 2022;16(3):180-4.
  6. Çalışkan A, Öner SZ, Demir M, Kaleli İ, Mete E, Ergin C. Antimicrobial Resistance Of E. Coli Strains Isolated From Urine Cultures. Anatolian Journal Of Pharmaceutical Sciences. 2024;3(2):212-9.
  7. Korkmazer R, Kayaaslan B, Kaya-Kalem A, Oktay Z, Eser F, Hasanoğlu İ, Et Al. Causative Microorganisms İn Community-Acquired Urinary Tract Infections And Risk Factors For The Development Of Infection With Extended-Spectrum Β-Lactamase-Producing Species. Infect Dis Clin Microbiol. 2024;6(2):112-22.
  8. Sarı S, Mıstık S, Sağıroğlu P. Evaluation Of Antibiograms Of Escherichia Coli Strains Isolated From Urinary Cultures. Konuralp Medical Journal. 2023;15(3):360-8.
  9. Mclellan LK, Hunstad DA. Urinary Tract Infection: Pathogenesis And Outlook. Trends Mol Med. 2016;22(11):946-57.
  10. Tuna A, Arslan F, Akkuş İ, Böke E, Şahin Ö, Kaçmaz B, Et Al. İdrar Kültürlerinden İzole Edilen Escherichia Coli Suşlarının Klinikte Sıkça Kullanılan Antibiyotiklere Karşı Direnç Oranlarının Araştırılması. The Journal Of Kırıkkale University Faculty Of Medicine. 2024;26(1):1-4.
  11. Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Et Al. International Clinical Practice Guidelines For The Treatment Of Acute Uncomplicated Cystitis And Pyelonephritis İn Women: A 2010 Update By The Infectious Diseases Society Of America And The European Society For Microbiology And Infectious Diseases. Clin Infect Dis. 2011;52(5):E103-20.
  12. Şamlıoğlu P, Kılıç I. Trimethoprim-Sulfamethoxazole And Ciprofloxacin Resistance Rates İn Escherichia Coli And Klebsiella Spp. İn Urinary Tract İnfections: A 10-Year Evaluation. Klimik Derg. 2023.
  13. Karakoc HN, Haykir Solay A, Arikan T, Gurbuz OA, Lale Z, Sencan I. Comprehensive Analysis Of Antibiotic Resistance İn Enterobacteriaceae From Outpatient Urine Cultures: Implications For Empirical Therapy. North Clin Istanb. 2025;12(1):36-44.
  14. Gündüz A, Mansur A. Antimicrobial Resistance Rates İn Escherichia Coli Strains İsolated İn Urine Cultures Of Outpatients: Five Years Analysis. Turkish Bulletin Of Hygiene And Experimental Biology. 2023;80(1):23-32.
  15. Nicolle LE, Gupta K, Bradley SF, Colgan R, Demuri GP, Drekonja D, Et Al. Clinical Practice Guideline For The Management Of Asymptomatic Bacteriuria: 2019 Update By The Infectious Diseases Society Of America. Clin Infect Dis. 2019;68(10):E83-E110.
  16. Kömürlüoğlu A, Aykaç K, Özsürekçi Y, Başaranoğlu ST, Bıçakçıgil A, Liste Ü, Et Al. Gram Negatif İdrar Yolu Enfeksiyonu Etkenlerinin Antibiyotik Direnç Dağılımı: Tek Merkez Deneyimi. Türkiye Çocuk Hastalıkları Dergisi. 2018;12(1):10-7.